ENERGENESIS BIOMEDICAL CO., LTD.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
Based on its ENERGI platform, the company is developing multiple novel therapeutics including ENERGI‑F705PD (an oral therapy for Parkinson’s disease) and ENERGI‑F703DFU (a gel for diabetic foot ulcers), committed to leveraging boosted cellular ATP and ant
The content above was translated by Ai
Founded Year
2012
Unified Business No.
53726093
Status
Active
Number of Employees
20
Total Paid-in
Capital
897,490,000 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
Listing(2023)
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Energenesis Biomedical Co., Ltd., founded in 2012 and recognized as a biopharmaceutical company in 2015, leverages its proprietary ENERGI platform to enhance cellular energy and activate self‑repair mechanisms, aiming to become a rising star in Taiwan’s biotech industry.
The content above was translated by Ai
